Back to User profile » Dr Yi Hu
Papers published by Dr Yi Hu:
Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial
Liu YT, Hao XZ, Liu DR, Cheng G, Zhang SC, Xiao WH, Hu Y, Liu JF, He M, Ding CM, Zhang L, Wang J, Li H, Dong GL, Zhi XY, Li J, Shi YK
Cancer Management and Research 2020, 12:4633-4643
Published Date: 17 June 2020
A New Regulatory Mechanism Between P53 And YAP Crosstalk By SIRT1 Mediated Deacetylation To Regulate Cell Cycle And Apoptosis In A549 Cell Lines
Yuan F, Wang J, Li R, Zhao X, Zhang Y, Liu B, Lei Y, Hu Y
Cancer Management and Research 2019, 11:8619-8633
Published Date: 23 September 2019
Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients
Liu Z, Wu L, Cao J, Yang Z, Zhou C, Cao L, Wu H, Shen H, Jin M, Zhang Y, Mao X, Xiang J, Ma K, Li B, Zhang T, Hu Y
OncoTargets and Therapy 2018, 11:7323-7331
Published Date: 23 October 2018
Pneumonitis and pneumonitis-related death in cancer patients treated with programmed cell death-1 inhibitors: a systematic review and meta-analysis
Cui P, Ma J, Wang F, Zhang J, Tao H, Hu Y
Therapeutics and Clinical Risk Management 2017, 13:1259-1271
Published Date: 25 September 2017